Fuwai Hospital Signs Pact With 13 Indonesian Hospitals
The five-year memorandum of understanding covers training, clinical exchanges, and cross-border referral for complex heart cases.
Updated on Nov. 5, 2026 in Heart Disease
Fuwai Hospital signed a five-year memorandum of understanding with 13 Indonesian hospitals at its Beijing campus on Monday. The agreement follows a Corheart-6 left ventricular assist device implant in Jakarta in August, the first Chinese-made LVAD implanted in Indonesia and Southeast Asia.
Why it matters
Cardiovascular care is one of the priority areas in Indonesia's healthcare transformation, and the agreement builds on cooperation dating to 2010. The partnership aims to expand access to advanced heart treatment through shared training and device use.
The agreement covers 13 Indonesian hospitals under a five-year memorandum, following more than 100 live demonstrations by Shu Chang in Indonesia since 2010. The source does not report patient outcomes from the August Corheart-6 implant or projected case volumes under the new pact.
The players
Fuwai Hospital
Fuwai Hospital is a leading Chinese cardiovascular medical center in Beijing's Xicheng district, widely known for heart surgery and device development.
Shu Chang
Shu Chang is a Chinese cardiac surgeon who has led cooperation with Indonesian surgeons since 2010 and holds an adjunct professorship at the University of Indonesia.
Indonesian Ministry of Health
The Indonesian Ministry of Health oversees the country's national healthcare system and is driving a healthcare transformation that prioritizes cardiovascular care.
The details
Signed by Hu Shengshou, president of Fuwai Hospital, and Azhar Jaya, director general of advanced health services at Indonesia's Ministry of Health, the memorandum sets out cooperation on training, clinical team exchanges, overseas use of Chinese-developed devices, and cross-border consultation for complex cases. A Fuwai team led by Wang Xianqiang flew to Jakarta to guide surgeons through the Corheart-6 implant at Dr Cipto Mangunkusumo National Central General Hospital.
Timeline
2010: Shu Chang begins cooperating with Indonesian surgeons.
2016: Fuwai signs its first five-year MoU with National Cardiovascular Center Harapan Kita.
2023: Fuwai signs a second MoU with Indonesia.
July 2024: Shu Chang is appointed adjunct professor at the University of Indonesia.
August: The Corheart-6 LVAD is implanted in Jakarta; Monday: the new memorandum is signed in Beijing.
Big Picture
The new pact extends Fuwai Hospital's 2016 five-year MoU with Harapan Kita and its 2023 agreement with Indonesia into a broader framework covering device use and cross-border referrals. It marks a continuation of a partnership that began with surgical cooperation in 2010.
For patients with advanced heart failure, the expanded cooperation could eventually mean access to Chinese-made assist devices and specialist consultation through partner hospitals. The source does not indicate when these services will be available to patients outside the initial trial sites.
The takeaway
Cross-border hospital partnerships can speed the transfer of specialized heart technology and surgical skills between countries. Readers interested in heart care options should discuss advanced device and referral options with their own cardiologist.
Further reading
For more on heart treatment advances, explore the Heart Disease section.
Source note: This article includes information reported by China Daily.
